183 related articles for article (PubMed ID: 17009253)
1. Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis.
Manicourt DH; Azria M; Mindeholm L; Thonar EJ; Devogelaer JP
Arthritis Rheum; 2006 Oct; 54(10):3205-11. PubMed ID: 17009253
[TBL] [Abstract][Full Text] [Related]
2. Biochemical markers identify influences on bone and cartilage degradation in osteoarthritis--the effect of sex, Kellgren-Lawrence (KL) score, body mass index (BMI), oral salmon calcitonin (sCT) treatment and diurnal variation.
Karsdal MA; Byrjalsen I; Bay-Jensen AC; Henriksen K; Riis BJ; Christiansen C
BMC Musculoskelet Disord; 2010 Jun; 11():125. PubMed ID: 20565725
[TBL] [Abstract][Full Text] [Related]
3. Comparative effect of nimesulide and ibuprofen on the urinary levels of collagen type II C-telopeptide degradation products and on the serum levels of hyaluronan and matrix metalloproteinases-3 and -13 in patients with flare-up of osteoarthritis.
Manicourt DH; Bevilacqua M; Righini V; Famaey JP; Devogelaer JP
Drugs R D; 2005; 6(5):261-71. PubMed ID: 16128596
[TBL] [Abstract][Full Text] [Related]
4. Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials.
Karsdal MA; Byrjalsen I; Alexandersen P; Bihlet A; Andersen JR; Riis BJ; Bay-Jensen AC; Christiansen C;
Osteoarthritis Cartilage; 2015 Apr; 23(4):532-43. PubMed ID: 25582279
[TBL] [Abstract][Full Text] [Related]
5. Cross sectional evaluation of biochemical markers of bone, cartilage, and synovial tissue metabolism in patients with knee osteoarthritis: relations with disease activity and joint damage.
Garnero P; Piperno M; Gineyts E; Christgau S; Delmas PD; Vignon E
Ann Rheum Dis; 2001 Jun; 60(6):619-26. PubMed ID: 11350852
[TBL] [Abstract][Full Text] [Related]
6. Oral salmon calcitonin induced suppression of urinary collagen type II degradation in postmenopausal women: a new potential treatment of osteoarthritis.
Bagger YZ; Tankó LB; Alexandersen P; Karsdal MA; Olson M; Mindeholm L; Azria M; Christiansen C
Bone; 2005 Sep; 37(3):425-30. PubMed ID: 16005273
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from MOKHA study.
Henrotin Y; Bannuru R; Malaise M; Ea HK; Confavreux C; Bentin J; Urbin-Choffray D; Conrozier T; Brasseur JP; Thomas P; Hick AC; Marinello A; Giordan N; Richette P
BMC Musculoskelet Disord; 2019 Jun; 20(1):293. PubMed ID: 31215422
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow abnormalities on magnetic resonance imaging are associated with type II collagen degradation in knee osteoarthritis: a three-month longitudinal study.
Garnero P; Peterfy C; Zaim S; Schoenharting M
Arthritis Rheum; 2005 Sep; 52(9):2822-9. PubMed ID: 16145678
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of a novel salmon calcitonin (sCT) technology-based oral formulation in healthy postmenopausal women: acute and 3-month effects on biomarkers of bone turnover.
Tankó LB; Bagger YZ; Alexandersen P; Devogelaer JP; Reginster JY; Chick R; Olson M; Benmammar H; Mindeholm L; Azria M; Christiansen C
J Bone Miner Res; 2004 Sep; 19(9):1531-8. PubMed ID: 15312255
[TBL] [Abstract][Full Text] [Related]
10. Cartilage turnover and intra-articular corticosteroid injections in knee osteoarthritis.
Klocke R; Levasseur K; Kitas GD; Smith JP; Hirsch G
Rheumatol Int; 2018 Mar; 38(3):455-459. PubMed ID: 29396701
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Chondroitin Sulfate for Painful Knee Osteoarthritis: A One-Year, Randomized, Double-Blind, Multicenter Clinical Study in Japan.
Morita M; Yamada K; Date H; Hayakawa K; Sakurai H; Yamada H
Biol Pharm Bull; 2018 Feb; 41(2):163-171. PubMed ID: 29176264
[TBL] [Abstract][Full Text] [Related]
12. Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study.
Martel-Pelletier J; Raynauld JP; Mineau F; Abram F; Paiement P; Delorme P; Pelletier JP
Arthritis Res Ther; 2017 Jul; 19(1):169. PubMed ID: 28728606
[TBL] [Abstract][Full Text] [Related]
13. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
[TBL] [Abstract][Full Text] [Related]
14. Effects of single or combined administration of salmon calcitonin and omega-3 fatty acids vs. diclofenac sodium in sodium monoiodoacetate-induced knee osteoarthritis in male Wistar rats.
Adeyemi WJ; Olayaki LA
J Basic Clin Physiol Pharmacol; 2017 Nov; 28(6):573-582. PubMed ID: 28917083
[TBL] [Abstract][Full Text] [Related]
15. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP
Arthritis Res Ther; 2008; 10(4):R85. PubMed ID: 18667054
[TBL] [Abstract][Full Text] [Related]
16. Glucosamine sulfate and cartilage type II collagen degradation in patients with knee osteoarthritis: randomized discontinuation trial results employing biomarkers.
Cibere J; Thorne A; Kopec JA; Singer J; Canvin J; Robinson DB; Pope J; Hong P; Grant E; Lobanok T; Ionescu M; Poole AR; Esdaile JM
J Rheumatol; 2005 May; 32(5):896-902. PubMed ID: 15868627
[TBL] [Abstract][Full Text] [Related]
17. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study.
Bingham CO; Buckland-Wright JC; Garnero P; Cohen SB; Dougados M; Adami S; Clauw DJ; Spector TD; Pelletier JP; Raynauld JP; Strand V; Simon LS; Meyer JM; Cline GA; Beary JF
Arthritis Rheum; 2006 Nov; 54(11):3494-507. PubMed ID: 17075851
[TBL] [Abstract][Full Text] [Related]
18. Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphate.
Christgau S; Henrotin Y; Tankó LB; Rovati LC; Collette J; Bruyere O; Deroisy R; Reginster JY
Clin Exp Rheumatol; 2004; 22(1):36-42. PubMed ID: 15005002
[TBL] [Abstract][Full Text] [Related]
19. Use of the plasma stromelysin (matrix metalloproteinase 3) concentration to predict joint space narrowing in knee osteoarthritis.
Lohmander LS; Brandt KD; Mazzuca SA; Katz BP; Larsson S; Struglics A; Lane KA
Arthritis Rheum; 2005 Oct; 52(10):3160-7. PubMed ID: 16200596
[TBL] [Abstract][Full Text] [Related]
20. A hyaluronic acid-salmon calcitonin conjugate for the local treatment of osteoarthritis: chondro-protective effect in a rabbit model of early OA.
Mero A; Campisi M; Favero M; Barbera C; Secchieri C; Dayer JM; Goldring MB; Goldring SR; Pasut G
J Control Release; 2014 Aug; 187():30-8. PubMed ID: 24837189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
